CLINICAL_TRIALS trial_result · 2017-01-31

Clinical Trial Update: A Study to Assess the Efficacy, Safety, and Tolerability of CAT-354 in Subjects With Asthma [Phase 2]

Phase 2 study evaluating the efficacy, safety, and tolerability of CAT-354 in subjects with asthma was terminated, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: MedImmune LLC | Conditions: Asthma | Phase 2 | Status: TERMINATED | Results posted: 2017-01-31